Adrenomedullin refines mortality prediction by the BODE index in COPD: the %26quot;BODE-A%26quot; index

作者:Stolz Daiana*; Kostikas Kostantinos; Blasi Francesco; Boersma Wim; Milenkovic Branislava; Lacoma Alicia; Louis Renaud; Aerts Joachim G; Welte Tobias; Torres Antoni; Rohde Gernot G U; Boeck Lucas; Rakic Janko; Scherr Andreas; Hertel Sabine; Giersdorf Sven; Tamm Michael
来源:European Respiratory Journal, 2014, 43(2): 397-408.
DOI:10.1183/09031936.00058713

摘要

The BODE (body mass index, airflow obstruction, dyspnoea, exercise capacity) index is well-validated for mortality prediction in chronic obstructive pulmonary disease (COPD). Concentrations of plasma pro-adrenomedullin, a surrogate for mature adrenomedullin, independently predicted 2-year mortality among inpatients with COPD exacerbation. %26lt;br%26gt;We compared accuracy of initial pro-adrenomedullin level, BODE and BODE components, alone or combined, in predicting 1-year or 2-year all-cause mortality in a multicentre, multinational observational cohort with stable, moderate to very severe COPD. %26lt;br%26gt;Pro-adrenomedullin was significantly associated (p%26lt;0.001) with 1-year mortality (4.7%) and 2-year mortality (7.8%) and comparably predictive to BODE regarding both (C statistics 0.691 versus 0.745 and 0.635 versus 0.679, respectively). Relative to using BODE alone, adding pro-adrenomedullin significantly improved 1-year and 2-year mortality prognostication (C statistics 0.750 and 0.818, respectively; both p%26lt;0.001). Pro-adrenomedullin plus BOD was more predictive than the original BODE including 6-min walk distance. In multivariable analysis, pro-adrenomedullin (likelihood ratio Chi-squared 13.0, p%26lt;0.001), body mass index (8.5, p=0.004) and 6-min walk distance (7.5, p=0.006) independently foretold 2-year survival, but modified Medical Research Council dyspnoea score (2.2, p=0.14) and forced expiratory volume in 1 s % predicted (0.3, p=0.60) did not. %26lt;br%26gt;Pro-adrenomedullin plus BODE better predicts mortality in COPD patients than does BODE alone; proadrenomedullin may substitute for 6-min walk distance in BODE when 6-min walk testing is unavailable.

  • 出版日期2014-2